<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0504233486
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2017
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        FLEXBUMIN 200GM/L SOLUTION FOR INFUSION
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        ALBUMIN HUMAN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        200
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        g/l
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for infusion
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        50
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bag
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Biological
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        156.55
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Baxalta US, Inc" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Baxalta US, Inc
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 583]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ALNAGHI COMPANY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Takeda Manufacturing AG
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        B05AA01 
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Flexbumin 200 g/l is a solution of plasma protein and belongs to the pharmacotherapeutic group of plasma<br />substitutes and plasma protein fractions. Plasma is the fluid in which blood cells are suspended.<br />Thismedicine is used for restoration andmaintenance of circulating blood volume when there is not enough blood volume.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not use Flexbumin 200 g/l<br />&ndash;&nbsp;&nbsp; &nbsp; if you are allergic to human albumin or any of the other ingredients of this medicine (listed in section 6).<br />Warnings and Precautions<br />Talk to your doctor, pharmacist or nurse before using Flexbumin 200 g/l.<br />&ndash;&nbsp;&nbsp; &nbsp; If you get headache, difficulties in breathing or feeling faint during the treatment please tell your doctor or nurse.<br />It can be an allergic reaction.<br />&ndash;&nbsp;&nbsp; &nbsp; If you have:<br />&ndash;&nbsp;&nbsp; &nbsp; decompensated heart failure<br />&ndash;&nbsp;&nbsp; &nbsp; high blood pressure<br />&ndash;&nbsp;&nbsp; &nbsp; oesophageal varices (swelled veins in the oesophagus)<br />&ndash;&nbsp;&nbsp; &nbsp; pulmonary oedema (fluid in the lungs)<br />&ndash;&nbsp;&nbsp; &nbsp; a tendency to spontaneous bleeding<br />&ndash;&nbsp;&nbsp; &nbsp; severe anemia (lack of red blood cells)<br />&ndash;&nbsp;&nbsp; &nbsp; decreased urine formation<br />inform your doctor so that he/she can take appropriate precautions.<br />When medicines are made from human blood or plasma, certain measures are put in place to prevent infections<br />being passed on to patients. These include careful selection of blood and plasma donors to make sure those at risk<br />of carrying infections are excluded, and the testing of each donation and pools of plasma for signs of virus/infections.<br />Manufacturers of these products also include steps in the processing of the blood or plasma that can inactivate or<br />remove viruses. Despite these measures, when medicines prepared from human blood or plasma are administered,<br />the possibility of passing on infection cannot be totally excluded. This also applies to any unknown or emerging<br />viruses or other types of infections.<br />There are no reports of virus infections with albumin manufactured to European Pharmacopoeia specifications by<br />established processes.<br />It is strongly recommended that every time you receive a dose of Flexbumin 200 g/l the name and batch number of<br />the product are recorded in order to maintain a record of the batches used.<br />Other medicines and Flexbumin 200 g/l<br />Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.<br />Pregnancy and breast-feeding<br />If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or<br />pharmacist for advice before taking this medicine. Your doctor will decide if you can use Flexbumin 200 g/l during<br />pregnancy or breast-feeding.<br />Driving and using machines<br />No effect on the ability to drive or use machines has been observed.<br />Flexbumin 200 g/l contains sodium<br />Flexbumin contains 130 &ndash; 160 mmol/l sodium. To be taken into consideration by patients on a controlled sodium diet.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Flexbumin 200 g/l is a medicine for hospital use. It will therefore be administered to you in a hospital by appropriate<br />health care personnel. Your doctor will determine the amount of product to be administered, the frequency of dosing<br />and the duration of treatment based on your specific condition.<br />If you use more Flexbumin 200 g/l than you should<br />It is highly unlikely that you will get an overdose since you receive the injection in a hospital by trained personnel.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.<br />Very common in more than 1 in 10 patients treated<br />Common in less than 1 in 10, but more than 1 in 100 patients treated<br />Uncommon in less than 1 in 100, but more than 1 in 1000 patients treated<br />Rare in less than 1 in 1000, but more than 1 in 10 000 patients treated<br />Very rare in less than 1 in 10 000 patients treated, including isolated cases<br />Very common Common Uncommon Rare Very rare<br />Immune system disorders anaphylactic shock<br />Gastrointestinal disorders nausea (feeling<br />sick)<br />Skin and subcutaneous<br />tissue disorders flushing, skin rash<br />General disorders and<br />administration site<br />conditions<br />fever<br />&bull;&nbsp;&nbsp; &nbsp; The rare side effects disappear quickly when the infusion rate is decreased or stopped.<br />&bull;&nbsp;&nbsp; &nbsp; If anaphylactic shock (severe allergic reactions) occurs, the infusion should be stopped immediately and<br />appropriate treatment initiated.<br />&bull;&nbsp;&nbsp; &nbsp; If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your<br />doctor or pharmacist.<br />Other side effects observed after placing Human Albumin on the market are: Hypersensitivity/Allergic reactions,<br />Headache, Rapid heart beat, Abnormally low blood pressure, Breathlessness or breathing discomfort, Vomiting,<br />Altered sense of taste, Hives, Itchiness, Chills, Heart attack, Irregular heart beat, Accumulation of fluid in the lung.<br />Reporting of side effects<br />If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed<br />in this leaflet. You can also report side effects directly via the national reporting system listed below.<br />To report any side effect(s):<br />&bull;&nbsp;&nbsp; &nbsp; Saudi Arabia:<br />&ndash;&nbsp;&nbsp; &nbsp; The National Pharmacovigilance and Drug Safety Centre (NPC)<br />&bull;&nbsp;&nbsp; &nbsp; Fax: +966-11-205-7662<br />&bull;&nbsp;&nbsp; &nbsp; Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.<br />&bull;&nbsp;&nbsp; &nbsp; Toll free phone: 8002490000<br />&bull;&nbsp;&nbsp; &nbsp; E-mail: npc.drug@sfda.gov.sa<br />&bull;&nbsp;&nbsp; &nbsp; Website: www.sfda.gov.sa/npc<br />&bull; Other GCC States:<br />&ndash;&nbsp;&nbsp; &nbsp; Please contact the relevant competent authority.<br />f. Council of Arab Health Ministers<br />The following statements issued by the Council of Arab Health Ministers should be printed in the PIL.<br />This is a Medicament<br />&ndash;&nbsp;&nbsp; &nbsp; Medicament is a product which affects your health and its consumption contrary to instructions is dangerous for you.<br />&ndash;&nbsp;&nbsp; &nbsp; Follow strictly the doctor&ldquo;s prescription, the method of use and the instructions of the pharmacist who sold the medicament.<br />&ndash;&nbsp;&nbsp; &nbsp; The doctor and the pharmacist are the experts in medicines, their benefits and risks.<br />&ndash;&nbsp;&nbsp; &nbsp; Do not by yourself interrupt the period of treatment prescribed for you.<br />&ndash;&nbsp;&nbsp; &nbsp; Do not repeat the same prescription without consulting your doctor.<br />&ndash;&nbsp;&nbsp; &nbsp; Keep all medicaments out of reach of children.<br />Council of Arab Health Ministers<br />Union of Arab Pharmacists</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.<br />Do not use this medicine after the expiry date which is stated on the bag and the carton. The expiry date refers to<br />the last day of that month.<br />store below 30 &deg;C<br />Do not freeze.<br />Keep the bag in the outer carton in order to protect from light.<br />Once the package has been opened, the contents must be used immediately.<br />Do not use Flexbumin 200 g/l if you notice that the solution is cloudy or has deposits.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What Flexbumin 200 g/l contains<br />&ndash;&nbsp;&nbsp; &nbsp; The active substance is human albumin.<br />&nbsp;&nbsp; &nbsp; 1 liter of solution contains 200 g of total protein, of which at least 95% is human albumin.<br />&ndash;&nbsp;&nbsp; &nbsp; The other ingredients are sodium chloride, sodium caprylate, sodium acetyltryptophanate and water for injections.<br />Total amount of sodium ions: 130 &ndash;160 mmol/l<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                What Flexbumin 200 g/l looks like and contents of the pack
Flexbumin 200 g/l is presented as a solution for infusion in a bag. Pack sizes are 12 x 100 ml (2 boxes of 6 or 12
single units), 24 x 50 ml (2 boxes of 12 or 24 single units), 1 x 100 ml (single unit) and 1 x 50 ml (single unit).
The solution is clear and slightly viscous, almost colourless, yellow, amber or green.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Baxter AG Vienna<br />Importation, storage, Quality control and batch release<br />Baxalta US Inc.<br />Los Angles, CA 90039 USA<br />Bulk formulation &amp; Heat treatment<br />Baxalta US Inc.<br />Illinois 60073, USA<br />Sterile filling, final pasteurization, packaging &amp; release.<br />For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:<br />Baxalta GmbH Export Services, now part of Shire<br />2964 Immam Saud Bin Faisal St &ndash; Alsahafa dist.<br />Brand Tower 6th floor, Apart. No. 61<br />Riyadh 13321 &ndash; 6106, Kingdom of Saudi Arabia<br />Tel: 011 485 4949</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last approved in 10/2015
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>فليكسبومني 200 جم / لرت عبارة عن محلول من بروتني بالزما ينتمي إىل املجموعة الدوائية العالجية الخاصة ببدائل البالزما وآسور<br />بروتني البالزما. يستخدم هذا الدواء للتعويض والحفاظ عىل حجم الدم الجاري عندما ال يكون هناك ما يكفي من حجم الدم.<br />1 لرت من املحلول يحتوي عىل 200 جم من الربوتني الكيل، منها ما ال يقل عن95 ٪ من األلبومني البرشي.<br />&nbsp;&nbsp; &nbsp; املكونات األخرى هي آلوريد الصوديوم 35.4 جم/ل، وآابريالت الصوديوم 66.2 جم/ل، استيل تريبتوفانيت الصوديوم<br />29.4 جم/ل و ماء للحقن الوريدي.<br />إجامىل الكمية من ايونات الصوديوم: 130-160-مل مول/لر</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>ال تستخدم فليكسبومني 200 جم/لرت<br />- - إذا آنت تشكو من حساسية تجاه األلبومني البرشي )مدرجة ىف القسم 6 ) ّ أو أي من املكونات األخرى الخاصة<br />بفليكسبومني 200 جم/ لرت.<br />تحذیرات و احتیاطات<br />تحدث إىل طبيبك، الصيديل او املمرض قبل إستخدام فليكسبومني 200 جم/ لرت.<br />- - اذا أصبت بصداع ، وصعوبات يف التنفس أو شعور باإلغامء أثناء العالج يرجى إخبار الطبيب أو املمرضة. ميكن أن يكون<br />ذلك تفاعل حساسية.<br />إذا كنت تعاين من:<br />- فشل القلب غري املعاوض<br />- ارتفاع ضغط الدم<br />- دوايل املريء )تضخم األوردة يف املريء(<br />- وذمة رئوية )سائل يف الرئتني(<br />- امليل للنزيف التلقاىئ<br />- انيميا حدة )نقص ىف كريات الدم الحمراء(<br />- نقص ىف تكوين البول<br />أبلغ الطبيب حتى ميكنه اتخاذ االحتياطات املناسبة.<br />عند تحضري أدوية مشتقة من الدم البرشي أو البالزما، تتخذ تدابري معينة ملنع انتقال العدوى للمرىض. يشمل ذلك<br />االختيار الدقيق للمتربعني بالدم و البالزما للتأكد من استبعاد أولئك الحاملني لخطر العدوى، واختبار كل متربع و كمية<br />البالزما للكشف عن عالمات وجود فريوسات / عدوى. الرشكات املصنعة لهذه املنتجات تقوم أيضاً بادخال<br />خطوات يف معالجة الدم أو البالزما من شأنها وقف نشاط أو إزالة الفريوسات. وعىل الرغم من هذه التدابري، عند<br />فريوسات غري معروفة أو ناشئة أو أنواع أخرى من العدوى. ً استخدام األدوية املحرضة من الدم البرشي أو البالزما ال ميكن استبعاد انتقال العدوى متام ّ ا. وهذا ينطبق أيضا عىل أي<br />ً مل ترد تقارير عن انتقال العدوى بالفريوس مع األلبومني الذي تم تصنيعه وفقا ملواصفات دستور األدوية األورويب من خالل<br />الطرق املتعارف عليها.<br />من املستحسن تسجيل اسم ورقم تشغيلة املنتج يف آل مرة تتلقى جرعة من فليكسبومني 200 جم/لرت من أجل االحتفاظ<br />بسجل للتشغيالت املستخدمة.<br />استخدام أدوية أخرى<br />يرجى إخبار الطبيب أو الصيديل إذا آنت تأخذ أو قمت يف اآلونة األخرية بأخذ أي أدوية أخرى، مبا يف ذلك األدوية التي يتم<br />الحصول عليها بدون وصفة طبية.<br />الحمل والرضاعة الطبيعية<br />ِ إذغ كنت ِ حامالً او مرضع او تظبني أنك حامالً او تخططني للحمل إستشريي طبيبك أو الصيديل قبل أخذ الدواء. سوف يقرر<br />طبيبك ما إن كان ميكنك استخدام فليكسبومني 200 جم /لرت خالل فرتة الحمل أو الرضاعة الطبيعية.<br />القيادة واستخدام اآلالت<br />مل يالحظ أي تأثري عىل القدرة عىل القيادة أو استخدام اآلالت.<br />فليكسبومني 200 جم/لرت يحتوي عىل صوديوم<br />فليكسبومني 200 جم/لرت يحتوي عىل 130 &ndash; 160 مل مول/لرت من الصوديوم. لألخذ يف الحسبان للمرىض الذين هم عىل نظام<br />غذاىئ للسيطرة الصوديم.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>ليكسبومني 200 جم /لرت هو دواء لالستخدام يف املستشفيات. لذلك سوف يتم اعطاءه لك يف املستشفى من قبل<br />القامئني عىل الرعاية الصحية املناسبني. سوف يقوم طبيبك بتحديد الكمية املستخدمة من املنتج، ومعدل تكرار<br />الجرعات وفترة العلاج بناءً عىل حالتك الخاصة<br />إذا استخدمت فليكسبومني 200 جم /لرت بكمية أكرب مام يجب<br />من غري املرجح ان تحصل عىل جرعة زائدة مبا انك تتلقى الحقنة يف املستشفى من قبل موظفني مدربن</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>شأنه شأن جميع األدوية، ميكن أن يتسبب فليكسبومني 200 جم /لرت يف آثار جانبية، عىل الرغم من عدم تعرض الجميع لها.<br />ً شائع جدا يف أكرث من 1 يف 10 من املرىض الذين عولجوا<br />شائع يف أقل من 1 يف 10 ، ولكن أآثر من 1 يف 100 من املرىض الذين عولجوا<br />غري شائع يف أقل من 1 يف 100 ، ولكن أآثر من 1 يف 1000 من املرىض الذين عولجوا<br />نادر ىف أقل من 1 ىف 1000 ،ولكن أكرث من 1 ىف 10000 من املرض الذين عولجوا<br />نادر جداً ىف أفل من 10000 من املرىض الذين عولجوا، مبا ىف ذلك حاالت معزولة<br />ً شائع جدا شائع غري شائع نادر نادر جداً<br />اضطرابات<br />الجهاز املناعي<br />صدمة فرط<br />الحساسية<br />اضطرابات<br />الجهاز الهضمي<br />غثيان ) الشعور<br />باالعياء(<br />االضطرابات<br />الجلدية و<br />األنسجة تحت<br />الجلدية<br />تبيغ، طفح جلدي<br />اضطرابات عامة حمى<br />الحاالت التي<br />تحدث يف مكان<br />الحقن<br />&bull; اآلثار الجانبية النادرة تختفي برسعة عند خفض معدل الحقن /الترسيب أو وقفه.<br />&bull; ً إذا حدثت صدمة فرط الحساسية ) تفاعالت تحسسية حادة(، يجب وقف الحقن /الترسيب فورا، والبدء يف العالج املناسب.<br />&bull; إذا اشتدت أي من اآلثار الجانبية، أو إذا الحظت أي آثار جانبية غري مدرجة يف هذه النرشة، يرجى إخبار الطبيب أو الصيديل.<br />هناك آثار جانبية أخرى تم مالحظتها بعد تسويق األلبومني البرشي وهي : تفاعالت فرط الحساسية ،الصداع ، رسعة رضبات القلب،<br />انخفاض ضغط الدم بشكل غري عادي، ضيق التنفس أو عدم الراحة يف التنفس القيء، تغري حاسة التذوق، رشى، حكة، و رعشة.<br />اإلبالغ عن اآلثار الجانبية:<br />ُصبت بأي آثار جانبية، فتحدث مع طبيبك أو الصيديل. يشمل هذا أي آثار جانبية محتملة غري مدرجة يف هذه النرشة.<br />إذا أ<br />املساعدة يف توفري املزيد من املعلومات حول سالمة هذا الدواء. ً ميكنك أيضا اإلبالغ عن اآلثار الجانبية مبارشة عن طريق نظام اإلبالغ الوطني املذكور أدناه. بإبالغك عن اآلثار الجانبية، ميكنك<br />&nbsp;&nbsp; &nbsp; اململكة العربية السعودية:<br />&nbsp;&nbsp; &nbsp; املركز الوطني للتيقظ والسالمة الدوائية<br />+966-11-2057662 :فاكس &bull;<br />&nbsp;&bull; اتصل باملركز الوطني للتيقظ والسالمة الدوائية عىل رقم +966-11-2038222 ،الرقم الداخيل: 2317-2356-2353-<br />.2340-2334-2354<br />&nbsp;&bull; الهاتف املجاين: 8002490000<br />&nbsp;npc.drug@sfda.gov.sa :اإللكرتوين الربيد &bull;<br />&nbsp;www.sfda.gov.sa/npc :اإللكرتوين املوقع &bull;<br />&nbsp;&bull;دول مجلس التعاون الخليجي األخرى:<br />&nbsp;&nbsp; &nbsp; يرجى االتصال بالسلطة املختصة ذات الصلة.<br />وضع اإلرشادات الصادرة من مجلس وزراء الصحة العرب كام يىل:<br />إن هذا الدواء<br />&nbsp;&nbsp; &nbsp; الدواء مستحرض يؤثر عىل صحتك وإستهالكه خالفاً للتعليامت يعرضك للخطر.<br />&nbsp;&nbsp; &nbsp; إتبع بدقة وصفة الطبيب وطريقة اإلستعامل املنصوص عليها وتعليامت الصيدىل الذى رصفها لك.<br />&nbsp;&nbsp; &nbsp; إن الطبيب والصدىل هام الخبريان ىف الدواء وبنفعه ورضره.<br />&nbsp;&nbsp; &nbsp; ال تقطع مدة العالج املحددة مل من تلقاء نفسه.<br />&nbsp;&nbsp; &nbsp; ال تكرر رصف الدواء بدون إستشارة الطبيب.<br />&nbsp;&nbsp; &nbsp; ال ترتك الدواء ىف متناول األطفال.<br />مجلس وزراء الصحة العرب<br />وإتحاد الصيادلة العرب</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحفظ بعيدا عن متناول و مرأى األطفال.<br />ال تستخدم فليكسبومني 200 جم /لرت بعد انتهاء تاريخ الصالحية املذآورعىل العبوة و العلبة الخارجية. تاريخ انتهاء<br />الصالحية يشري إىل اليوم األخري من ذلك الشهر.<br />ال يخزن ىف درجة حرارة تتجاوز 30 درجة مئوية.<br />ال يجمد.<br />احفظ العبوة يف العلبة الخارجية لحاميتها من الضوء.<br />بمجرد فتح العبوة يجب استخدام المحتويات فوراً<br />ال تستخدم فليكسبومني 200 جم / لرت إذا الحظت أن املحلول غامئاً أو به رواسب.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحتوي فلكسبومني 200 جم / لرت املادة الفعالة هى ألبيومني برشي 1 لرت من املحلول يحتوي عىل 200 جم من الربوتني الكيل، منها ما ال يقل عن 95 % من األلبومني البرشي. املكونات األخرى هي كلوريد الصوديوم 35.4 جم/لرت، وكابريالت الصوديوم 66.2 جم/لرت، استيل تريبتوفانيت الصوديوم و ماء للحقن إجاميل كمية أيونات الصوديم: 130 &ndash; 160 مل مول/لرت كيف يبدو فلكسبومني 200 جم / لرت محتويات العبوة يقدم فلكسبومني 200 جم / لرت كمحلول للحقن/ للترسيب يف عبوة. أحجام العبوة هي 12 X 100 مل )صندوقني بهم 6 او 12 عبوة مفردة(، 24 X 50 مل )صندوقني بهم 12 او 24 عبوة مفردة(، 1 X 100 مل )عبوة مفردة( و 1 X 50 مل )عبوة مفردة(. قد ال تتوفر جمیع أحجام العبوات يف األسواق. ٍ املحلول صاف ولزج قليالً، عديم اللون تقريباً، أصفر، آهرماين أو أخر</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>-----</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>حامل ترصيح التسويق و الصانع<br />باكسرت ايه جي<br />اندسرتي سرتايس 67<br />أ - 1221 فيينا<br />النمسا<br />للمزید من املعلومات بخصوص ھذا الداء یرجى التواصل مع املكتب العلمي للرشكة:<br />باكسالتا إكسبورت سیرفیسیز جى ام ىب إتش<br />۲۹٦٤ طریق اإلمام سعود بن فیصل حى الصحافة<br />برج العالمة التجاریة الدور السادس، مكتب ٦۱<br />الریاض ۱۳۳۲۱ - اململكة العربیة السعودیة</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            متت املوافقة عىل هذه النرشة ىف أكتوبر 2015
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Flexbumin 200 g/l solution for infusion
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Flexbumin 200 g/l is a solution containing 200 g/l (20%) of total protein of which at least 95% is human
albumin.
A bag of 100 ml contains 20 g of human albumin.
A bag of 50 ml contains 10 g of human albumin
The solution is hyperoncotic.
Excipients with known effect:
Sodium 130-160 mmol/l
For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for infusion.
A clear, slightly viscous liquid; it is almost colourless, yellow, amber or green.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated,<br />and use of a colloid is appropriate.<br />The choice of albumin rather than artificial colloid will depend on the clinical situation of the individual<br />patient, based on official recommendations.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The concentration of the albumin preparation, dosage and the infusion rate should be adjusted to the<br />patient&rsquo;s individual requirements.<br />Posology<br />The dose required depends on the size of the patient, the severity of trauma or illness and on continuing<br />fluid and protein losses. Measures of adequacy of circulating volume and not plasma albumin levels should<br />be used to determine the dose required.<br />If human albumin is to be administered, haemodynamic performance should be monitored regularly; this<br />may include:<br />1<br />- arterial blood pressure and pulse rate<br />- central venous pressure<br />- pulmonary artery wedge pressure (PCW-pressure)<br />- urine output<br />- electrolyte<br />- haematocrit/haemoglobin<br />- clinical signs of cardiac/respiratory failure (e.g.dyspnoea)<br />- clinical signs of increasing intra-cranial pressure (e.g. headache)<br />Method of Administration<br />Flexbumin 200 g/l can be directly administered by the intravenous route, or it can also be diluted in an<br />isotonic solution (e.g. 5 % glucose or 0.9 % sodium chloride).<br />The infusion rate should be adjusted according to the individual circumstances and the indication.<br />In plasma exchange the infusion rate should be adjusted to the rate of removal.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to albumin preparations or to any of the excipients listed in section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Suspicion of allergic or anaphylactic type reactions requires immediate discontinuation of the injection. In<br />case of shock, standard medical treatment for shock should be implemented.<br />Albumin should be used with caution in conditions where hypervolaemia and its consequences or<br />haemodilution could represent a special risk for the patient. Examples of such conditions are:<br />- Decompensated cardiac insufficiency<br />- Hypertension<br />- Oesophageal varices<br />- Pulmonary oedema<br />- Haemorrhagic diathesis<br />- Severe anaemia<br />- Renal and post-renal anuria<br />The colloid-osmotic effect of human albumin 200 g/l or 250 g/l is approximately four times that of blood<br />plasma. Therefore, when concentrated albumin is administered, care must be taken to assure adequate<br />hydration of the patient. Patients should be monitored carefully to guard against circulatory overload and<br />hyperhydration.<br />200 g/l &ndash; 250 g/l Human albumin solutions are relatively low in electrolytes compared to the 40 &ndash; 50 g/l<br />human albumin solutions. When albumin is given, the electrolyte status of the patient should be monitored<br />(see section 4.2 Posology) and appropriate steps taken to restore or maintain the electrolyte balance.<br />Flexbumin contains 130-160 mmol/l sodium. To be taken into consideration by patients on a controlled<br />sodium diet.<br />Albumin solutions must not be diluted with water for injections as this may cause haemolysis in recipients.<br />If comparatively large volumes are to be replaced, controls of coagulation and haematocrit are necessary.<br />Care must be taken to ensure adequate substitution of other blood constituents (coagulation factors,<br />electrolytes, platelets and erythrocytes).<br />2<br />Hypervolaemia may occur if the dosage and rate of infusion are not adjusted to the patient&rsquo;s circulatory<br />situation. At the first clinical signs of cardiovascular overload (headache, dyspnoea, jugular vein<br />congestion), or increased blood pressure, raised venous pressure and pulmonary oedema, the infusion is to<br />be stopped immediately.<br />Standard measures to prevent infections resulting from the use of medicinal products prepared from human<br />blood or plasma include selection of donors, screening of individual donations and plasma pools for specific<br />markers of infection and the inclusion of effective manufacturing steps for the inactivation/removal of<br />viruses. Despite this, when medicinal products prepared from human blood or plasma are administered, the<br />possibility of transmitting infective agents cannot be totally excluded. This also applies to unknown or<br />emerging viruses and other pathogens.<br />There are no reports of virus transmissions with albumin manufactured to European Pharmacopoeia<br />specifications by established processes.<br />It is strongly recommended that every time that Flexbumin 200 g/l is administered to a patient, the name and<br />batch number of the product are recorded in order to maintain a link between the patient and the batch of the<br />product.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No interaction studies of Flexbumin 200 g/l with other medicinal products have been performed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The safety of Flexbumin 200 g/l for use in human pregnancy has not been established in controlled clinical<br />trials. However, clinical experience with albumin suggests that no harmful effects on the course of<br />pregnancy, or on the foetus and the neonate are to be expected.<br />The effects of human albumin on fertility have not been studied.<br />No animal reproduction studies have been conducted with Flexbumin 200 g/l.<br />Experimental animal studies are insufficient to assess the safety with respect to reproduction, development<br />of the embryo or foetus, the course of gestation and peri- and postnatal development.<br />However, human albumin is a normal constituent of human blood.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Flexbumin 200 g/l has no influence on the ability to drive and use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Frequency has been evaluated using the following criteria: very common (&ge;1/10), common (&ge;1/100 to<br />&lt;1/10), uncommon (&ge;1/1,000 to &lt;1/100), rare (&ge;1/10,000 to &lt;1/1,000), and very rare (&lt;1/10,000), not<br />known (cannot be estimated from the available data).<br />Very<br />common<br />Common Uncommon<br />Rare Very rare<br />Immune system<br />disorders<br />anaphylactic shock<br />Gastrointestinal<br />disorders<br />nausea<br />Skin and<br />subcutaneous<br />flushing, skin<br />rash<br />3<br />tissue disorders<br />General disorders<br />and administration<br />site conditions<br />fever<br />In cases of severe reactions, the infusion should be stopped and an appropriate treatment should be initiated.<br />In post-marketing surveillance the following adverse events have been reported. These<br />events are listed by MedDRA System Organ Class, then by Preferred Term in order of<br />severity.<br />Immune System Disorders: Anaphylactic reactions, Hypersensitivity/Allergic reactions<br />Nervous System Disorders: Headache, Dysguesia<br />Cardiac Disorders: Myocardial infarction, Atrial fibrillation, Tachycardia<br />Vascular Disorders: Hypotension<br />Respiratory, Thoracic, and Mediastinal Disorders: Pulmonary edema, Dyspnea<br />Gastrointestinal Disorders: Vomiting,<br />Skin and Subcutaneous Tissue Disorders: Urticaria, Pruritis<br />General Disorders and Administration Site Conditions: Chills<br />There are no data available on adverse reactions from clinical trials conducted with<br />Flexbumin (Human).<br />For safety with respect to transmissible agents, see 4.4.<br />&minus; To reports any side effect(s):<br />&bull; Saudi Arabia:<br />&minus; The National Pharmacovigilance and Drug Safety Centre (NPC)<br />o Fax: +966-11-205-7662<br />o Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.<br />o Toll free phone: 8002490000<br />o E-mail: npc.drug@sfda.gov.sa<br />o Website: www.sfda.gov.sa/npc<br />&bull; Other GCC States:<br />- Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Hypervolaemia may occur if the dosage and rate of infusion are too high. At the first clinical signs of<br />cardiovascular overload (headache, dyspnoea, jugular vein congestion), or increased blood pressure, raised<br />central venous pressure and pulmonary oedema, the infusion should be stopped immediately and the<br />patient&rsquo;s haemodynamic parameters carefully monitored.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: plasma substitutes and plasma protein fractions<br />ATC code: B05AA01.<br />Human albumin accounts quantitatively for more than half of the total protein in the plasma and represents<br />about 10 % of the protein synthesis activity of the liver.<br />Physico-chemical data: Human albumin 200 g/l or 250 g/l has a hyperoncotic effect.<br />The most important physiological functions of albumin result from its contribution to the oncotic pressure of<br />the blood and its transport function. Albumin stabilises circulating blood volume and is a carrier of<br />hormones, enzymes, medicinal products and toxins.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Under normal conditions, the total exchangeable albumin pool is 4 - 5 g/kg body weight, of which 40 to 45<br />% is present intravascularly and 55 to 60 % in the extravascular space. Increased capillary permeability will<br />alter albumin kinetics and abnormal distribution may occur in conditions such as severe burns or septic<br />shock.<br />Under normal conditions the average half life of albumin is about 19 days. The balance between synthesis<br />and breakdown is normally achieved by feed-back regulation. Elimination is predominantly intracellular and<br />due to lysosome proteases.<br />In healthy subjects, less than 10 % of infused albumin leaves the intravascular compartment during the first<br />two hours following infusion. There is considerable individual variation in the effect on plasma volume. In<br />some patients the plasma volume can remain increased for some hours. However, in critically ill patients,<br />albumin can leak out of the vascular space in substantial amounts at an unpredictable rate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Human albumin is a normal constituent of human plasma and acts like physiological albumin.<br />In animals, single dose toxicity testing is of little relevance and does not permit the evaluation of toxic or<br />lethal doses or of a dose-effect relationship. Repeated dose toxicity testing is impracticable due to the<br />development of antibodies to heterologous protein in animal models.<br />To date, human albumin has not been reported to be associated with embryo-foetal toxicity, oncogenic or<br />mutagenic potential.<br />No signs of acute toxicity have been described in animals models.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sodium chloride 4.3 g/l<br />Sodium caprylate 2.7 g/l<br />Sodium acetyltryptophanate 4.3 g/l<br />Water for injections<br />5<br />Total amount of sodium ions 130 &ndash; 160 mmol/l</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>This medicinal product must not be mixed with other medicinal products (except those mentioned in 6.6),<br />whole blood or packed red cells.<br />Further human albumin should not be mixed with protein hydrolysates (e.g. parenteral nutrition) or solutions<br />containing alcohol since these combinations may cause the proteins to precipitate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30 &deg;C.<br />Do not freeze.<br />Keep the bag in the outer carton in order to protect from light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>50 or 100 ml of solution in a polyethylene bag, with an infusion port (polyethylene).<br />Pack sizes: 24 x 50 ml (2 boxes of 12 or 24 single units)<br />12 x 100 ml (2 boxes of 6 or 12 single units)<br />1 x 50 ml (single unit)<br />1 x 100 ml (single unit)<br />Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The solution can be directly administered by the intravenous route, or it can also be diluted in an isotonic<br />solution (e.g. 5 % glucose or 0.9% sodium chloride).<br />Albumin solutions must not be diluted with water for injections as this may cause haemolysis in recipients.<br />If large volumes are administered, the product should be warmed to room or body temperature before use.<br />Do not use solutions which are cloudy or have deposits. This may indicate that the protein is unstable or<br />that the solution has become contaminated.<br />Use only if the seal is intact. Discard in case of leak<br />Once the container has been opened, the contents should be used immediately. Any unused medicinal<br />product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Baxter AG
Industriestraße 67
A-1221 Vienna
Austria
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                01-10-2015
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>